Plain-English translation of NCT06939686 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Miro3D Wound Matrix, a special biological dressing made from porcine liver material, to see if it helps diabetic foot ulcers heal better when combined with standard wound care. The dressing is designed to create a scaffold that encourages your body's own healing processes. Researchers will compare people who receive this new dressing plus standard care to people who receive standard care alone.
Diabetic foot ulcers are a serious complication that affects many people with diabetes and can lead to amputation if they don't heal properly. While standard wound care helps some people, many ulcers still fail to heal adequately, so doctors need better treatment options to improve outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the new Miro3D dressing plus standard wound care, or standard wound care alone. Whichever group you're in, you will visit the clinic weekly for 12 weeks for wound checks, measurements, and to assess your healing progress and pain level. If you're in the treatment group, the dressing will be applied once a week for the first 4 weeks, then every 2 weeks if your wound hasn't fully healed. If you're in the standard care group and your wound hasn't healed after 12 weeks, you may have the option to switch to the new dressing treatment.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States